secwatch.observer — SEC 8-K summary
======================================

Issuer:     Tempest Therapeutics, Inc. (TPST)
CIK:        0001544227
Form:       8-K
Filed at:   2023-03-31T23:59:59+00:00
Accession:  0001193125-23-088320
Event type: litigation
Sentiment:  neutral
Materiality: 0.50
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Tempest Therapeutics reports preliminary approval of OvaScience derivative settlement
--------------------------------------------------------------------------------

- Cima v. Dipp derivative lawsuit settlement received preliminary court approval on March 23, 2023.
- Upon final approval of the Cima settlement, a motion to dismiss the related Chiu v. Dipp action will be filed.
- Settlement involves claims against OvaScience (predecessor) and former officers for alleged breach of fiduciary duties.
- Settlement terms are described in a notice available on Tempest's investor website.
- Litigation stems from OvaScience's January 2015 follow-on public offering.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1544227/000119312523088320/0001193125-23-088320-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1544227/000119312523088320/d495297d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-088320

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer